D. E. Shaw & Co., Inc. Opko Health, Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.87 - $1.57 $2.78 Million - $5.02 Million	-3,196,453 Reduced 54.71%	2,646,084 $3.18 Million
Q4 2023 Feb 14, 2024	SELL	$1.23 - $1.63 $394,709 - $523,070	-320,902 Reduced 5.21%	5,842,537 $8.82 Million
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.17 $690,021 - $998,230	460,014 Added 8.07%	6,163,439 $9.86 Million
Q2 2023 Aug 14, 2023	BUY	$1.37 - $2.17 $591,091 - $936,255	431,454 Added 8.18%	5,703,425 $12.4 Million
Q1 2023 May 15, 2023	SELL	$1.06 - $1.61 $545,058 - $827,871	-514,206 Reduced 8.89%	5,271,971 $7.7 Million
Q4 2022 Feb 14, 2023	SELL	$1.05 - $2.01 $191,235 - $366,079	-182,129 Reduced 3.05%	5,786,177 $7.23 Million
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.81 $720,217 - $1.12 Million	-397,910 Reduced 6.25%	5,968,306 $11.3 Million
Q2 2022 Aug 15, 2022	BUY	$2.33 - $3.61 $2.31 Million - $3.58 Million	990,990 Added 18.44%	6,366,216 $16.1 Million
Q1 2022 May 16, 2022	BUY	$2.87 - $4.93 $3.71 Million - $6.38 Million	1,294,225 Added 31.71%	5,375,226 $18.5 Million
Q4 2021 Feb 14, 2022	BUY	$3.52 - $5.15 $7.05 Million - $10.3 Million	2,003,147 Added 96.4%	4,081,001 $19.6 Million
Q3 2021 Nov 15, 2021	SELL	$3.44 - $4.24 $1.65 Million - $2.03 Million	-478,728 Reduced 18.73%	2,077,854 $7.58 Million
Q2 2021 Aug 16, 2021	SELL	$3.33 - $4.55 $3.26 Million - $4.45 Million	-979,049 Reduced 27.69%	2,556,582 $10.4 Million
Q1 2021 May 17, 2021	BUY	$4.19 - $5.99 $14.7 Million - $21 Million	3,505,182 Added 11511.65%	3,535,631 $15.2 Million
Q4 2020 Feb 16, 2021	SELL	$3.27 - $4.87 $1.64 Million - $2.44 Million	-500,490 Reduced 94.27%	30,449 $120,000
Q3 2020 Nov 16, 2020	SELL	$2.99 - $5.96 $2.07 Million - $4.12 Million	-690,879 Reduced 56.55%	530,939 $1.96 Million
Q2 2020 Aug 14, 2020	BUY	$1.15 - $3.41 $1.41 Million - $4.17 Million	1,221,818 New	1,221,818 $4.17 Million
Q1 2020 May 15, 2020	SELL	$1.34 - $2.32 $1.83 Million - $3.17 Million	-1,367,150 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.42 - $2.17 $1.18 Million - $1.8 Million	-831,068 Reduced 37.81%	1,367,150 $2.01 Million
Q3 2019 Nov 14, 2019	BUY	$1.75 - $2.47 $1.17 Million - $1.65 Million	666,879 Added 43.55%	2,198,218 $4.59 Million
Q2 2019 Aug 14, 2019	SELL	$1.79 - $2.61 $331,214 - $482,943	-185,036 Reduced 10.78%	1,531,339 $3.74 Million
Q1 2019 May 15, 2019	BUY	$2.42 - $3.83 $4.1 Million - $6.48 Million	1,692,210 Added 7002.73%	1,716,375 $4.48 Million
Q4 2018 Feb 14, 2019	BUY	$2.46 - $3.87 $10,095 - $15,882	4,104 Added 20.46%	24,165 $73,000
Q3 2018 Nov 14, 2018	SELL	$3.29 - $6.29 $1.39 Million - $2.65 Million	-421,574 Reduced 95.46%	20,061 $69,000
Q2 2018 Aug 14, 2018	BUY	$2.99 - $4.99 $1.23 Million - $2.06 Million	412,564 Added 1419.16%	441,635 $2.08 Million
Q1 2018 May 15, 2018	SELL	$3.11 - $5.12 $111,086 - $182,881	-35,719 Reduced 55.13%	29,071 $92,000
Q4 2017 Feb 14, 2018	SELL	$4.61 - $7.04 $311,917 - $476,333	-67,661 Reduced 51.08%	64,790 $317,000
Q3 2017 Nov 14, 2017	BUY	$5.88 - $7.11 $778,811 - $941,726	132,451	132,451 $909,000

Others Institutions Holding OPK

# of Institutions

259

Shares Held

199M

Call Options Held

3.58M

Put Options Held

9.18M

Rubric Capital Management LP New York, NY

48.7M
Shares

$81.8 Million
1.18% of portfolio
Black Rock Inc. New York, NY

29.2M
Shares

$49.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

29.2M
Shares

$49.1 Million
0.0% of portfolio
State Street Corp Boston, MA

9.07M
Shares

$15.2 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

8.39M
Shares

$14.1 Million
0.0% of portfolio

View Full List

About OPKO HEALTH, INC.

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.3B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

More about OPK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account